Yuki, Satoshi
Shinozaki, Katsunori
Kashiwada, Tomomi
Kusumoto, Tetsuya
Iwatsuki, Masaaki
Satake, Hironaga
Kobayashi, Kazuma
Esaki, Taito
Nakashima, Yuichiro
Kawanaka, Hirofumi
Emi, Yasunori
Komatsu, Yoshito
Shimokawa, Mototsugu
Makiyama, Akitaka
Saeki, Hiroshi
Oki, Eiji http://orcid.org/0000-0002-9763-9366
Baba, Hideo
Mori, Masaki
Funding for this research was provided by:
Yakult Honsha (KSCC1501B)
Article History
Received: 21 July 2019
Accepted: 7 November 2019
First Online: 25 November 2019
Compliance with ethical standards
:
: This study was supported by funding from Yakult Honsha Co., Ltd. S. Yuki has received honoraria for lecturing, from Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan, K.K., Takeda Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Bristol-Meyers Squibb Co., Ltd., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Taiho Pharmaceutical Co., Ltd., Yakult Honsha Co., Ltd., and Merck Serono Co., Ltd. E. Oki has received honoraria for lecturing, from Bayer Yakuhin, Ltd., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson K.K., Merck Serono Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Yakult Honsha Co., Ltd. All remaining authors have declared no conflicts of interest.